Avandia linked to heart attacks
The Senate Finance Committee conducted an investigation of the diabetes drug, Avandia which links the drug to an increased risk of heart attacks. It is estimated that by July 2007, Avandia was associated with approximately 83,000 heart attacks since the drug came to market. The Senate’s Committee reports that GlaxoSmithKline, the manufacturer of Avandia, knew of the risks for years.
The report states: “Had GSK considered Avandia’s potential increased cardiovascular risk more seriously when the issue was first raised in 1999 some of these heart attacks may have been avoided.”
GlaxoSmithKline counters that the Senate report relies on outdated information.
Click this LINK for the report.